A detailed history of Israel Englander (Millennium Management LLC) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 244,640 shares of PLRX stock, worth $3.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
244,640
Previous 73,290 233.8%
Holding current value
$3.23 Million
Previous $787,000 248.41%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.52 - $14.35 $1.8 Million - $2.46 Million
171,350 Added 233.8%
244,640 $2.74 Million
Q2 2024

Aug 14, 2024

BUY
$10.58 - $15.61 $452,305 - $667,343
42,751 Added 139.99%
73,290 $787,000
Q1 2024

May 15, 2024

BUY
$14.14 - $19.59 $431,821 - $598,259
30,539 New
30,539 $455,000
Q2 2023

Aug 14, 2023

SELL
$18.12 - $30.56 $258,028 - $435,174
-14,240 Reduced 3.83%
357,563 $6.48 Million
Q1 2023

May 15, 2023

BUY
$18.73 - $36.26 $3.09 Million - $5.99 Million
165,072 Added 79.85%
371,803 $9.89 Million
Q4 2022

Feb 14, 2023

BUY
$17.0 - $25.43 $218,433 - $326,750
12,849 Added 6.63%
206,731 $4 Million
Q3 2022

Nov 14, 2022

SELL
$7.67 - $24.23 $201,958 - $638,000
-26,331 Reduced 11.96%
193,882 $4.05 Million
Q2 2022

Aug 15, 2022

BUY
$4.11 - $8.75 $666,420 - $1.42 Million
162,146 Added 279.24%
220,213 $1.76 Million
Q1 2022

May 16, 2022

SELL
$7.01 - $14.1 $43,433 - $87,363
-6,196 Reduced 9.64%
58,067 $407,000
Q4 2021

Feb 14, 2022

BUY
$12.27 - $18.26 $378,738 - $563,631
30,867 Added 92.43%
64,263 $868,000
Q3 2021

Nov 15, 2021

BUY
$16.48 - $28.98 $264,948 - $465,911
16,077 Added 92.83%
33,396 $564,000
Q2 2021

Aug 16, 2021

SELL
$28.05 - $37.69 $1.29 Million - $1.74 Million
-46,047 Reduced 72.67%
17,319 $504,000
Q1 2021

May 17, 2021

BUY
$24.52 - $40.23 $774,096 - $1.27 Million
31,570 Added 99.29%
63,366 $2.49 Million
Q4 2020

Feb 16, 2021

BUY
$19.89 - $32.99 $291,348 - $483,237
14,648 Added 85.42%
31,796 $722,000
Q3 2020

Nov 16, 2020

SELL
$21.54 - $29.53 $1.14 Million - $1.56 Million
-52,920 Reduced 75.53%
17,148 $388,000
Q2 2020

Aug 14, 2020

BUY
$21.3 - $35.26 $1.49 Million - $2.47 Million
70,068 New
70,068 $2.27 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $643M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.